Write a Comment

Catherine Hanssens, CHLP

Am I missing something here? The study was retrospective, and it also appears that the analysis eliminated the 45% of the deferred group who did not have a CD4 decline. If one assumes that none of those who did not have a CD4 count decline died then the crude death rate in the deferred group would be lower than the early treatment group. After all, if you chose to initiate therapy early, you cannot predict who would not have had a CD4 decline. The shortcomings of the analysis are outrageous.

April 6, 2009 • New York

gregory

someone needs to reread the study - 22% of participant data was excluded - only 16% of deaths were included and those were from non-AIDS related conditions ... ie caused by the hiv drugs that have black box warning labels on them? but the "Monte Carlo" simulations method cited in the journal article was really over the top. please see the new film with all the key players in AIDS research at houseofnumbers dawt com - AIDS is being rewritten for future generations.

April 4, 2009 • palm springs

apostle shada mishe

At what cost??

April 3, 2009 • toronto